← Leaderboards
Gregory A Hollman
University Of Wisconsin Madison
$241,369
Attributed
$241,369
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $11.9K · FY2005–06$20K$15K$10K$5K$0
'05
'06
Funding mix
By agency
NIH$241,369 · 3
By mechanism
M01$241,369 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- George Wilding$32,976,854
- Howard H Bailey$27,057,671
- Robert F Lemanske$29,535,752
- Joan H Schiller$7,395,575
- Marc K. Drezner$89,176,275
Others in their field
Top investigators on “Cardiovascular Disorder Chemotherapy”
- James F Toole · Wake Forest University Health Sciences$17,951,480
- Christopher M O'Connor · Duke University$16,943,599
- Leslie L Robison · University Of Minnesota Twin Cities$16,102,450
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$14,553,633
- Dan M Roden · Vanderbilt University Medical Center$11,317,563
- Andrew G. Bostom · Rhode Island Hospital (Providence, Ri)$10,300,000
Research focus
Cardiovascular Disorder ChemotherapyClinical ResearchHuman SubjectHuman Therapy EvaluationNitric OxidePulmonary HypertensionRespirators
Grant awards (7)
PROPOFOL VERSUS PROPOFOL-FENTANYL AS SEDATION FOR LUMBAR PUNCTURE IN CHILDREN$3,460
M01 · FY2006 · RR · contact PI
PROPOFOL VERSUS PROPOFOL-FENTANYL AS SEDATION FOR LUMBAR PUNCTURE IN CHILDREN$11,854
M01 · FY2005 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF NEONATAL &ADULT PULMONARY HYPE$106,600
M01 · FY2002 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF NEONATAL &ADULT PULMONARY HYPE$106,600
M01 · FY2001 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF NEONATAL &ADULT PULMONARY HYPE$12,855
M01 · FY2001 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF NEONATAL &ADULT PULMONARY HYPE$0
M01 · FY2000 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF NEONATAL &ADULT PULMONARY HYPE$0
M01 · FY2000 · RR